title: Association study of Val66Met polymorphism in brain-derived neurotrophic factor gene with clozapine-induced metabolic syndrome: preliminary results.
abstract: The prevalence of the metabolic syndrome (MetS) is higher among patients receiving atypical antipsychotics (AAPs) treatment, and even among AAPs, treatment with clozapine has been shown to be associated with a higher long-term incidence rate of MetS. Likewise, brain-derived neurotrophic factor (BDNF) deficiency has been reported to result in metabolic traits, such as increased food intake, hyperphagia and obesity, etc. In this study, we hypothesized that a functional polymorphism (Val66Met) in the BDNF gene may confer susceptibility to clozapine-induced MetS, potentially in a sex-specific manner, since an interaction between Val66Met polymorphism and sex was observed in our previous studies. A total of 199 schizophrenia patients being treated with clozapine were divided into two groups, MetS and non-MetS, based on the diagnostic criteria of the National Cholesterol Education Program's Adult Treatment Panel III. We genotyped the Val66Met polymorphism, and measured the serum levels of fasting glucose (GLU), triglyceride (TG) and high density lipoprotein cholesterol (HDL). There was a trend indicating a significant association between the homozygous Met/Met genotype and MetS in male patients (OR = 2.39; 95% CI: 1.05-5.41; p = 0.039; corrected p = 0.078). Among the six risk factors listed in the ATPIII criteria, we found a significant association between fasting GLU levels and Val66Met polymorphism in males (p = 0.005; corrected p = 0.03), but not in females (p = 0.65). Post-hoc analysis in males revealed that the Met/Met carriers had significant higher levels of fasting GLU than those with Val/Val or Val/Met genotypes (p = 0.007; corrected p = 0.042 and p = 0.002; corrected p = 0.012, respectively). In conclusion, we observed a weak association between the Val66Met polymorphism and clozapine-induced MetS in a sex-specific manner. While preliminary, such findings prompt further, large-scale longitudinal studies to replicate these findings.
authors: Schizophrenia Program, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
authors: Yi
authors: Y
authors: Zhang
authors: Meijuan
authors: M
authors: Chen
authors: Zhiguo
authors: Z
authors: Wu
authors: Jun
authors: J
authors: Chen
authors: Shunying
authors: S
authors: Yu
authors: Yiru
authors: Y
authors: Fang
authors: Chen
authors: C
authors: Zhang
mesh_terms: D000483:Alleles; D019943:Amino Acid Substitution; D019208:Brain-Derived Neurotrophic Factor / Q000235:genetics*; D003024:Clozapine / Q000009:adverse effects; D003062:Codon; D003430:Cross-Sectional Studies; D005260:Female; D056726:Genetic Association Studies; D005838:Genotype; D006801:Humans; D008297:Male; D024821:Metabolic Syndrome / Q000139:chemically induced / Q000235:genetics*; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D012702:Serotonin Antagonists / Q000009:adverse effects
chemical_list: D019208:Brain-Derived Neurotrophic Factor; D003062:Codon; D012702:Serotonin Antagonists; D003024:Clozapine
references: Med Sci Sports Exerc. 2008 Mar;40(3):535-41
references: 18379218
references: Am J Physiol Regul Integr Comp Physiol. 2007 Sep;293(3):R988-91
references: 17596322
references: Med Hypotheses. 2013 Apr;80(4):486-9
references: 23375407
references: Atherosclerosis. 2008 Dec;201(2):378-84
references: 18417137
references: Neuromolecular Med. 2011 Dec;13(4):328-33
references: 21956459
references: Brain Res. 2011 Apr 12;1384:51-60
references: 21281620
references: Arch Physiol Biochem. 2001 Oct;109(4):357-60
references: 11935372
references: Chemistry. 2012 Dec 3;18(49):15618-31
references: 23135810
references: Curr Opin Endocrinol Diabetes Obes. 2010 Oct;17(5):460-6
references: 20717020
references: Cochrane Database Syst Rev. 2010 Nov 10;(11):CD006633
references: 21069690
references: Am J Med Genet B Neuropsychiatr Genet. 2005 Jan 5;132B(1):96-9
references: 15457498
references: Endocrinology. 2003 Jun;144(6):2446-53
references: 12746306
references: Cell. 2003 Jan 24;112(2):257-69
references: 12553913
references: J Mol Neurosci. 2012 Jul;47(3):505-10
references: 22477643
references: J Alzheimers Dis. 2010;21(1):57-63
references: 20421697
references: Diabetes. 2010 Dec;59(12):3085-9
references: 20843981
references: Curr Opin Drug Discov Devel. 2006 Sep;9(5):580-6
references: 17002218
references: Psychopharmacology (Berl). 2013 Nov;230(1):49-55
references: 23660601
references: Riv Psichiatr. 2009 Mar-Apr;44(2):79-87
references: 20066808
references: Clin Chim Acta. 2012 May 18;413(9-10):944-8
references: 22374129
references: J Obes. 2012;2012:102942
references: 23326649
references: Front Hum Neurosci. 2008 Oct 03;2:12
references: 18958212
references: Prog Neuropsychopharmacol Biol Psychiatry. 2012 Oct 1;39(1):96-101
references: 22642961
references: Am J Psychiatry. 2006 Apr;163(4):600-10
references: 16585434
references: Behav Brain Funct. 2010 Dec 29;6:75
references: 21190551
references: Diabetologia. 2007 Feb;50(2):431-8
references: 17151862
references: Exp Neurol. 1995 Feb;131(2):229-38
references: 7534721
references: Brain Res. 2011 Oct 12;1417:146-50
references: 21917241
references: Cell Res. 2005 Feb;15(2):97-8
references: 15740637
references: Am J Med Genet B Neuropsychiatr Genet. 2011 Dec;156B(8):949-59
references: 21990008
references: Eur J Hum Genet. 2005 Apr;13(4):428-34
references: 15657604
references: Schizophr Res. 2013 May;146(1-3):285-8
references: 23433505
references: Metabolism. 2000 Jan;49(1):129-33
references: 10647076
references: Circulation. 2001 Sep 18;104(12):1336-42
references: 11560847
references: Clin Transl Sci. 2012 Dec;5(6):486-90
references: 23253673
references: J Neuroendocrinol. 2007 Dec;19(12):974-82
references: 18001327
references: J Psychiatr Res. 2007 Dec;41(12):997-1004
references: 17095017
references: Biomed Res. 2008 Jun;29(3):147-53
references: 18614848
references: Diabetes Res Clin Pract. 2010 Dec;90(3):319-25
references: 20934770
references: Neuroreport. 2004 Dec 3;15(17):2665-8
references: 15570174
references: Schizophr Bull. 2013 Mar;39(2):306-18
references: 22207632
references: Diabetes. 2006 Dec;55(12):3366-71
references: 17130481
references: Neuropsychopharmacology. 2008 Aug;33(9):2200-5
references: 17987059
references: Schizophr Res. 2008 Apr;101(1-3):295-303
references: 18299188
references: Circulation. 2005 Oct 25;112(17):2735-52
references: 16157765
references: Am J Physiol Regul Integr Comp Physiol. 2004 Jun;286(6):R994-1004
references: 15142855
references: Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15239-44
references: 10611369
references: Lancet. 2001 Sep 22;358(9286):971-6
references: 11583751